Annual CFF
-$229.93 M
+$22.03 M+8.74%
31 December 2023
Summary:
Integra LifeSciences Holdings annual cash flow from financing activities is currently -$229.93 million, with the most recent change of +$22.03 million (+8.74%) on 31 December 2023. During the last 3 years, it has fallen by -$351.55 million (-289.04%). IART annual CFF is now -119.67% below its all-time high of $1.17 billion, reached on 31 December 2017.IART Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$19.91 M
+$73.83 M+78.76%
30 September 2024
Summary:
Integra LifeSciences Holdings quarterly cash flow from financing activities is currently -$19.91 million, with the most recent change of +$73.83 million (+78.76%) on 30 September 2024. Over the past year, it has increased by +$29.74 million (+59.90%). IART quarterly CFF is now -103.00% below its all-time high of $664.21 million, reached on 31 December 2017.IART Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$238.12 M
+$29.74 M+14.27%
30 September 2024
Summary:
Integra LifeSciences Holdings TTM cash flow from financing activities is currently $238.12 million, with the most recent change of +$29.74 million (+14.27%) on 30 September 2024. Over the past year, it has increased by +$558.86 million (+174.24%). IART TTM CFF is now -79.63% below its all-time high of $1.17 billion, reached on 31 December 2017.IART TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IART Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.7% | +59.9% | +174.2% |
| 3 y3 years | -289.0% | -1242.6% | +407.2% |
| 5 y5 years | -27.1% | -124.6% | +2298.9% |
IART Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -289.0% | +8.7% | -105.5% | +87.8% | -18.3% | +174.2% |
| 5 y | 5 years | -289.0% | +8.7% | -105.5% | +87.8% | -18.3% | +174.2% |
| alltime | all time | -119.7% | +8.7% | -103.0% | +87.8% | -79.6% | +174.2% |
Integra LifeSciences Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$19.91 M(-78.8%) | $238.12 M(+14.3%) |
| June 2024 | - | -$93.75 M(-126.1%) | $208.38 M(-28.5%) |
| Mar 2024 | - | $358.68 M(-5305.7%) | $291.43 M(-226.8%) |
| Dec 2023 | -$229.93 M(-8.7%) | -$6.89 M(-86.1%) | -$229.93 M(-28.3%) |
| Sept 2023 | - | -$49.66 M(+364.4%) | -$320.73 M(+15.1%) |
| June 2023 | - | -$10.69 M(-93.4%) | -$278.72 M(-0.9%) |
| Mar 2023 | - | -$162.68 M(+66.5%) | -$281.17 M(+11.6%) |
| Dec 2022 | -$251.95 M(+156.5%) | -$97.70 M(+1178.4%) | -$251.95 M(+63.9%) |
| Sept 2022 | - | -$7.64 M(-41.9%) | -$153.73 M(+6.5%) |
| June 2022 | - | -$13.15 M(-90.1%) | -$144.35 M(-36.9%) |
| Mar 2022 | - | -$133.47 M(<-9900.0%) | -$228.68 M(+132.8%) |
| Dec 2021 | -$98.23 M(-180.8%) | $521.00 K(-70.1%) | -$98.23 M(+26.7%) |
| Sept 2021 | - | $1.74 M(-101.8%) | -$77.53 M(-31.0%) |
| June 2021 | - | -$97.47 M(+3133.0%) | -$112.32 M(+158.8%) |
| Mar 2021 | - | -$3.02 M(-114.2%) | -$43.40 M(-135.7%) |
| Dec 2020 | $121.63 M(-1487.5%) | $21.22 M(-164.2%) | $121.63 M(+560.6%) |
| Sept 2020 | - | -$33.05 M(+15.7%) | $18.41 M(-86.1%) |
| June 2020 | - | -$28.55 M(-117.6%) | $132.49 M(-10.4%) |
| Mar 2020 | - | $162.00 M(-297.6%) | $147.85 M(-1786.6%) |
| Dec 2019 | -$8.77 M(-95.2%) | -$81.99 M(-201.2%) | -$8.77 M(-19.1%) |
| Sept 2019 | - | $81.03 M(-714.2%) | -$10.83 M(-91.8%) |
| June 2019 | - | -$13.19 M(-344.6%) | -$131.69 M(-14.8%) |
| Mar 2019 | - | $5.39 M(-106.4%) | -$154.59 M(-14.5%) |
| Dec 2018 | -$180.87 M(-115.5%) | -$84.06 M(+111.0%) | -$180.87 M(-131.9%) |
| Sept 2018 | - | -$39.84 M(+10.4%) | $567.40 M(-36.5%) |
| June 2018 | - | -$36.09 M(+72.8%) | $893.61 M(-7.2%) |
| Mar 2018 | - | -$20.89 M(-103.1%) | $963.02 M(-17.6%) |
| Dec 2017 | $1.17 B(-7833.2%) | $664.21 M(+131.9%) | $1.17 B(+125.4%) |
| Sept 2017 | - | $286.37 M(+759.4%) | $518.50 M(+144.2%) |
| June 2017 | - | $33.32 M(-82.0%) | $212.33 M(+32.7%) |
| Mar 2017 | - | $185.04 M(+1244.5%) | $159.97 M(-1158.3%) |
| Dec 2016 | -$15.12 M(-106.1%) | $13.76 M(-169.5%) | -$15.12 M(-67.6%) |
| Sept 2016 | - | -$19.80 M(+4.0%) | -$46.64 M(-121.3%) |
| June 2016 | - | -$19.03 M(-291.3%) | $218.47 M(-19.7%) |
| Mar 2016 | - | $9.95 M(-156.0%) | $271.92 M(+9.6%) |
| Dec 2015 | $248.14 M(+4.0%) | -$17.76 M(-107.2%) | $248.14 M(-9.3%) |
| Sept 2015 | - | $245.31 M(+612.8%) | $273.54 M(+1719.2%) |
| June 2015 | - | $34.42 M(-348.9%) | $15.04 M(-182.1%) |
| Mar 2015 | - | -$13.83 M(-281.0%) | -$18.32 M(-107.7%) |
| Dec 2014 | $238.68 M(+1155.0%) | $7.64 M(-157.9%) | $238.68 M(+3.5%) |
| Sept 2014 | - | -$13.19 M(-1342.2%) | $230.56 M(-5.5%) |
| June 2014 | - | $1.06 M(-99.6%) | $243.93 M(-6.9%) |
| Mar 2014 | - | $243.17 M(<-9900.0%) | $261.94 M(+1277.2%) |
| Dec 2013 | $19.02 M(+61.9%) | -$488.00 K(-365.2%) | $19.02 M(-14.8%) |
| Sept 2013 | - | $184.00 K(-99.0%) | $22.32 M(-1.2%) |
| June 2013 | - | $19.07 M(+7318.7%) | $22.60 M(-8.0%) |
| Mar 2013 | - | $257.00 K(-90.9%) | $24.57 M(+109.1%) |
| Dec 2012 | $11.75 M(-80.5%) | $2.82 M(+512.4%) | $11.75 M(-164.7%) |
| Sept 2012 | - | $460.00 K(-97.8%) | -$18.17 M(-202.4%) |
| June 2012 | - | $21.03 M(-267.5%) | $17.74 M(-80.7%) |
| Mar 2012 | - | -$12.56 M(-53.7%) | $92.03 M(+53.0%) |
| Dec 2011 | $60.14 M(-3920.6%) | -$27.11 M(-174.5%) | $60.14 M(-52.2%) |
| Sept 2011 | - | $36.38 M(-61.8%) | $125.92 M(+139.7%) |
| June 2011 | - | $95.32 M(-314.4%) | $52.54 M(-243.7%) |
| Mar 2011 | - | -$44.45 M(-214.9%) | -$36.56 M(+2223.1%) |
| Dec 2010 | -$1.57 M | $38.67 M(-204.5%) | -$1.57 M(-97.1%) |
| Sept 2010 | - | -$37.00 M(-694.9%) | -$53.36 M(-24.2%) |
| June 2010 | - | $6.22 M(-165.7%) | -$70.37 M(-54.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$9.46 M(-27.8%) | -$152.85 M(-10.8%) |
| Dec 2009 | -$171.34 M(-211.6%) | -$13.11 M(-75.7%) | -$171.34 M(+79.1%) |
| Sept 2009 | - | -$54.01 M(-29.2%) | -$95.69 M(-314.6%) |
| June 2009 | - | -$76.26 M(+172.8%) | $44.59 M(+873.9%) |
| Mar 2009 | - | -$27.96 M(-144.7%) | $4.58 M(-97.0%) |
| Dec 2008 | $153.54 M(+41.5%) | $62.54 M(-27.5%) | $153.54 M(+109.7%) |
| Sept 2008 | - | $86.27 M(-174.2%) | $73.20 M(-949.1%) |
| June 2008 | - | -$116.27 M(-196.1%) | -$8.62 M(-103.7%) |
| Mar 2008 | - | $121.00 M(-780.0%) | $232.85 M(+114.6%) |
| Dec 2007 | $108.48 M(+137.7%) | -$17.79 M(-500.4%) | $108.48 M(+0.1%) |
| Sept 2007 | - | $4.44 M(-96.5%) | $108.32 M(-2.4%) |
| June 2007 | - | $125.20 M(-3821.7%) | $110.97 M(+421.9%) |
| Mar 2007 | - | -$3.36 M(-81.3%) | $21.26 M(-53.4%) |
| Dec 2006 | $45.64 M(-194.4%) | -$17.96 M(-353.2%) | $45.64 M(+31.1%) |
| Sept 2006 | - | $7.09 M(-80.0%) | $34.81 M(+20.1%) |
| June 2006 | - | $35.49 M(+68.9%) | $28.99 M(-197.9%) |
| Mar 2006 | - | $21.01 M(-173.0%) | -$29.60 M(-38.8%) |
| Dec 2005 | -$48.34 M(+495.6%) | -$28.78 M(-2368.2%) | -$48.34 M(+174.3%) |
| Sept 2005 | - | $1.27 M(-105.5%) | -$17.62 M(-45.7%) |
| June 2005 | - | -$23.10 M(-1113.2%) | -$32.44 M(+358.7%) |
| Mar 2005 | - | $2.28 M(+18.2%) | -$7.07 M(-12.9%) |
| Dec 2004 | -$8.12 M(-108.6%) | $1.93 M(-114.2%) | -$8.12 M(+80.9%) |
| Sept 2004 | - | -$13.55 M(-697.8%) | -$4.49 M(-143.3%) |
| June 2004 | - | $2.27 M(+83.3%) | $10.37 M(-61.8%) |
| Mar 2004 | - | $1.24 M(-77.8%) | $27.17 M(-71.3%) |
| Dec 2003 | $94.67 M(-4745.4%) | $5.56 M(+323.9%) | $94.67 M(+6.7%) |
| Sept 2003 | - | $1.31 M(-93.1%) | $88.73 M(+1.0%) |
| June 2003 | - | $19.07 M(-72.3%) | $87.89 M(+26.8%) |
| Mar 2003 | - | $68.74 M(<-9900.0%) | $69.33 M(-3501.7%) |
| Dec 2002 | -$2.04 M(-101.9%) | -$389.00 K(-182.6%) | -$2.04 M(-207.7%) |
| Sept 2002 | - | $471.00 K(-6.7%) | $1.89 M(-98.2%) |
| June 2002 | - | $505.00 K(-119.2%) | $106.80 M(+0.0%) |
| Mar 2002 | - | -$2.63 M(-174.1%) | $106.79 M(-2.4%) |
| Dec 2001 | $109.46 M(+666.9%) | $3.54 M(-96.6%) | $109.46 M(+2.4%) |
| Sept 2001 | - | $105.38 M(>+9900.0%) | $106.93 M(+1215.1%) |
| June 2001 | - | $498.00 K(+1176.9%) | $8.13 M(-0.6%) |
| Mar 2001 | - | $39.00 K(-96.2%) | $8.18 M(-42.7%) |
| Dec 2000 | $14.27 M(+27.9%) | $1.01 M(-84.6%) | $14.27 M(-5.6%) |
| Sept 2000 | - | $6.58 M(+1100.7%) | $15.12 M(+81.3%) |
| June 2000 | - | $548.00 K(-91.1%) | $8.34 M(+14.4%) |
| Mar 2000 | - | $6.13 M(+229.9%) | $7.29 M(-34.7%) |
| Dec 1999 | $11.16 M(+196.6%) | $1.86 M(-1029.0%) | $11.16 M(+19.2%) |
| Sept 1999 | - | -$200.00 K(-60.0%) | $9.36 M(0.0%) |
| June 1999 | - | -$500.00 K(-105.0%) | $9.36 M(-32.0%) |
| Mar 1999 | - | $10.00 M(>+9900.0%) | $13.76 M(+265.8%) |
| Dec 1998 | $3.76 M(+840.5%) | $62.00 K(-131.0%) | $3.76 M(-1.0%) |
| Sept 1998 | - | -$200.00 K(-105.1%) | $3.80 M(-5.0%) |
| June 1998 | - | $3.90 M(>+9900.0%) | $4.00 M(+3900.0%) |
| Mar 1998 | - | $0.00(-100.0%) | $100.00 K(-75.0%) |
| Dec 1997 | $400.00 K(-98.9%) | $100.00 K(>+9900.0%) | $400.00 K(+33.3%) |
| Sept 1997 | - | $0.00(0.0%) | $300.00 K(+50.0%) |
| June 1997 | - | $0.00(-100.0%) | $200.00 K(-50.0%) |
| Mar 1997 | - | $300.00 K(>+9900.0%) | $400.00 K(-98.9%) |
| Dec 1996 | $36.50 M(+5114.3%) | $0.00(-100.0%) | $36.50 M(0.0%) |
| Sept 1996 | - | -$100.00 K(-150.0%) | $36.50 M(-0.3%) |
| June 1996 | - | $200.00 K(-99.5%) | $36.60 M(+0.5%) |
| Mar 1996 | - | $36.40 M | $36.40 M |
| Dec 1995 | $700.00 K | - | - |
FAQ
- What is Integra LifeSciences Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual CFF year-on-year change?
- What is Integra LifeSciences Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly CFF year-on-year change?
- What is Integra LifeSciences Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM CFF year-on-year change?
What is Integra LifeSciences Holdings annual cash flow from financing activities?
The current annual CFF of IART is -$229.93 M
What is the all time high annual CFF for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual cash flow from financing activities is $1.17 B
What is Integra LifeSciences Holdings annual CFF year-on-year change?
Over the past year, IART annual cash flow from financing activities has changed by +$22.03 M (+8.74%)
What is Integra LifeSciences Holdings quarterly cash flow from financing activities?
The current quarterly CFF of IART is -$19.91 M
What is the all time high quarterly CFF for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly cash flow from financing activities is $664.21 M
What is Integra LifeSciences Holdings quarterly CFF year-on-year change?
Over the past year, IART quarterly cash flow from financing activities has changed by +$29.74 M (+59.90%)
What is Integra LifeSciences Holdings TTM cash flow from financing activities?
The current TTM CFF of IART is $238.12 M
What is the all time high TTM CFF for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM cash flow from financing activities is $1.17 B
What is Integra LifeSciences Holdings TTM CFF year-on-year change?
Over the past year, IART TTM cash flow from financing activities has changed by +$558.86 M (+174.24%)